Cargando…

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs

OBJECTIVES: The study aimed to assess the burden of RA among the US Medicare population (aged ≥65 years) by comparing co-morbidities, health-care resource utilization (HCRU) and costs against matched non-RA Medicare patients. METHODS: Data were obtained from the Medicare fee-for-service claims datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chieh-I, Wang, Li, Wei, Wenhui, Yuce, Huseyin, Phillips, Kristine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649951/ https://www.ncbi.nlm.nih.gov/pubmed/31431954 http://dx.doi.org/10.1093/rap/rky005

Ejemplares similares

Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
por: Kozlowski, Steven, et al.
Publicado: (2022)

Association of Medicare Program Type with Healthcare Utilization Among People Experiencing Homelessness
por: Chandrashekar, Pooja, et al.
Publicado: (2022)

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)

Reduced cognitive ability in people with rheumatoid arthritis compared with age-matched healthy controls
por: Gwinnutt, James M, et al.
Publicado: (2021)

Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases
por: Shrestha, Sulena, et al.
Publicado: (2017)

Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis
por: Alcaraz, María José, et al.
Publicado: (2022)

US Health Resource Utilization and Cost Burden Associated with Choroideremia
por: Dong, Shaobin, et al.
Publicado: (2021)

Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
por: Schwenzer, Anja, et al.
Publicado: (2019)

Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit
por: Ulijn, Evy, et al.
Publicado: (2022)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritis
por: Gaboury, Isabelle, et al.
Publicado: (2022)

Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey
por: Scott, Ian C, et al.
Publicado: (2018)

Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
por: Conaghan, Philip G, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)
por: Wong-Pack, Matthew, et al.
Publicado: (2023)

Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes
por: Mistry, Jatin, et al.
Publicado: (2020)

Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
por: Tony, Hans-Peter, et al.
Publicado: (2022)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Should quantitative assessment of rheumatoid arthritis include measures of joint damage and patient distress, in addition to measures of apparent inflammatory activity?
por: Pincus, Theodore, et al.
Publicado: (2022)

Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis—a study using CoVariant protein arrays
por: Lin, Wei-Hsun, et al.
Publicado: (2023)

Racial and Ethnic Disparities in the Burden and Cost of Diabetes for US Medicare Beneficiaries
por: Glantz, Namino M., et al.
Publicado: (2019)

Ambulatory Care Sensitive Condition Admission Rates in Younger and Older Traditional Medicare and Medicare Advantage Populations, 2011–2019
por: Weeks, William B., et al.
Publicado: (2021)

Beyond the visual analog scale: results from a multimodal pain assessment pilot study in first‐degree relatives of patients with rheumatoid arthritis
por: McDougall, Cairistin, et al.
Publicado: (2022)

Characteristics of patients associated with any outpatient antibiotic prescribing among Medicare Part D enrollees, 2007–2018
por: Kim, Christine Y., et al.
Publicado: (2023)

Preventable Health Behaviors, COVID-19 Severity Perceptions, and Vaccine Uptake in Traditional Medicare and Medicare Advantage: a Survey-Based Study
por: Park, Sungchul, et al.
Publicado: (2021)

Comparison of outpatient antibiotic prescriptions among older adults in IQVIA Xponent and publicly available Medicare Part D data, 2018
por: Beshearse, Elizabeth M., et al.
Publicado: (2023)

Adoption of Telehealth Benefits by Medicare Advantage Plans in 2020 and 2021
por: Park, Sungchul, et al.
Publicado: (2021)

1019. Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2020)

Impact of on-site compared to off-site testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) on duration of isolation and resource utilization
por: Roberts, Andrew T., et al.
Publicado: (2020)

Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27–July 14, 2020
por: Wu, Hsiu, et al.
Publicado: (2021)

Impact of Medicare payment policy on home health resources utilization
por: Irvine, Audrey, et al.
Publicado: (1991)

Associations of Cost Sharing With Rheumatoid Arthritis Disease Burden
por: Dowell, Sharon, et al.
Publicado: (2023)

Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritis
por: Kim, Hyoungyoung, et al.
Publicado: (2021)

Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
por: Patel, Sadiq Y., et al.
Publicado: (2022)

Provider and Patient Characteristics of Medicare Beneficiaries Who Are High-Risk for COVID-19 Mortality
por: Ballreich, Jeromie, et al.
Publicado: (2021)

Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges
por: Zhou, Lindsay, et al.
Publicado: (2022)

The influence of constraints on the efficient allocation of resources for HIV prevention
por: Stopard, Isaac J., et al.
Publicado: (2019)

Disaster impacts on cost and utilization of Medicare
por: Rosenheim, Nathanael, et al.
Publicado: (2018)

A Real-World Analysis of Patient Characteristics and Predictors of Hospitalization Among US Medicare Beneficiaries with Respiratory Syncytial Virus Infection
por: Wyffels, Veronique, et al.
Publicado: (2020)

Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey
por: Solomon, Daniel H, et al.
Publicado: (2013)

Duration of psoriatic arthritis as a risk factor for myocardial infarction
por: Egeberg, Alexander, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a4onvhosa97hctmiojuu62dro9